AVROBIO approves $250K in transaction bonuses for CEO and CTO tied to cystinosis program sale

Tectonic Therapeutic, Inc.

Transaction bonuses of $150k for President/Interim CEO/CFO Erik Ostrowski and $100k for CTO Azadeh Golipour, payable in three installments after Asset Sale closing.
Bonuses contingent on closing of previously announced sale of cystinosis gene therapy program; forfeiture if resignation/termination before payment.
Stockholders elected directors Ian Clark and Annalisa Jenkins as Class II directors for term until 2026 annual meeting.
Ratification of Ernst & Young as independent auditor for FY2023 with over 34 million votes for.

item 5.02 item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Tectonic Therapeutic, Inc. shareholders approved Election of two Class II directors at the 2023-06-06 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-06

Exact text from the filing

The Company’s stockholders elected the two director nominees listed below to serve as Class II directors until the Company’s 2026 annual meeting of stockholders, with the votes cast as follows: Director Nominee Votes For Votes Withheld Broker Non-Votes Ian Clark 20,810,217 5,332,015 8,660,564 Annalisa Jenkins, M.B.B.S., F.R.C.P. 16,685,601 9,456,631 8,660,564

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Tectonic Therapeutic, Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-06 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-06

Exact text from the filing

The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, with the votes cast as follows: Votes For Votes Against Abstentions Broker Non-Votes 34,092,579 33,201 677,016 --

View on SEC.gov

1639 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Tectonic Therapeutic, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-23-029124

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.